Bacterial strain | Relevant features | Reference |
---|---|---|
Escherichia coli | ||
ATCC 8739 and ATCC 10536 | Reference strains | |
AG100 | Wild-type E. coli K-12 | Viveiros et al. (2005) |
AG100ATet | ΔacrAB mutant of AG100; TETR owing to acrF gene markedly overexpressed | Elkins and Mullis (2007) |
AG102 | AG100 over-expressing AcrAB pump | |
Enterobacter aerogenes | ||
ATCC 13048 | Reference strain | |
EA-CM64 | CHLR variant obtained from | Ghisalberti et al. (2005) |
EA3 | ATCC 13048 overexpressing AcrAB pump | Pradel and Pagès (2002) |
Clinical MDR isolate exhibiting energy-dependent | ||
Norfloxacin and chloramphenicol efflux with KANR AMPR | ||
NALR STRR TETR | ||
EA27 | Clinical MDR isolate exhibiting | |
Energy-dependent NOR and | ||
CHL efflux; KANR AMPR NALR | ||
STRR TETR | ||
EA289 | KAN-sensitive derivative of EA27 | |
EA294 | EA289 acrA::KANR | |
EA289 | EA289 tolC::KANR | |
Klebsiella pneumoniae | ||
ATCC 11296 | Reference strain | |
Kp55 | Clinical MDR isolate, TETR | Chevalier et al. (2000) |
Kp63 | AMPR ATMR CEFR | |
Clinical MDR isolate, TETR CHLR | ||
AMPR ATMR | ||
Pseudomonas aeruginosa | ||
PA01 | Reference strain | |
PA124 | MDR clinical isolate | Lorenzi et al. (2009) |
Staphyloccocus aureus | ||
ATCC1026 | Reference strain | |
SA3 | Clinical Laboratory isolate, sensitive to methicilin | |
SA4 | ||
SA11 | ||
SA12 | Clinical laboratory isolate, METR | |
MRSA 3 | Dzoyem et al. (2013) | |
MRSA 4 | ||
MRSA 6 | ||
MRSA 8 |